Detailed phenotyping of Tbr1-2A-CreER knock-in mice demonstrates significant impacts on TBR1 protein levels and axon development.
The popular Tbr1-2A-CreER mouse already shows reduced TBR1 and brain wire thinning, so it cannot serve as a normal control.
01Research in Context
What this study did
Co et al. (2025) looked at a special mouse line called Tbr1-2A-CreER. Scientists often use this line to study autism genes.
The team measured TBR1 protein levels and took brain scans. They wanted to know if the inserted genetic tag changes the mice.
What they found
The mice made less TBR1 protein than normal. Their anterior commissure, a cable of nerve fibers, was also thinner.
The allele acts like a weak, or hypomorphic, version. It is not a true normal control.
How this fits with other research
Chuang et al. (2015) mapped 24 genes that TBR1 switches on. Marissa's work now shows the same lab's mouse model has real physical flaws, not just gene-list changes.
Quesnel et al. (2026) saw similar thinning in ATRX-deficient mice. Both models share midline white-matter loss, pointing to a common brain wire problem across autism genes.
Ellegood et al. (2011) found corpus callosum thinning in NL3 mice. Marissa's TBR1 mice echo that pattern, adding evidence that callosal defects are a repeated theme in autism models.
Why it matters
If you run studies with Tbr1-2A-CreER mice, treat heterozygotes as affected, not as normal controls. Check baseline protein assays and MRI before starting behavior work. Pick a different wild-type line or adjust your stats to account for built-in brain changes.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Email your research partner and ask if your Tbr1-2A-CreER colony has baseline MRI or Western blot data.
02At a glance
03Original abstract
Cre recombinase knock-in mouse lines have served as invaluable genetic tools for understanding key developmental processes altered in autism. However, insertion of exogenous DNA into the genome can have unintended effects on local gene regulation or protein function that must be carefully considered. Here, we analyze a recently generated Tbr1-2A-CreER knock-in mouse line, where a 2A-CreER cassette was inserted in-frame before the stop codon of the transcription factor gene Tbr1. Heterozygous TBR1 mutations in humans and mice are known to cause autism or autism-like behavioral phenotypes accompanied by structural brain malformations, most frequently a reduction of the anterior commissure (AC). Thus, it is critical for modified versions of Tbr1 to exhibit true wild-type-like activity. We evaluated the Tbr1-2A-CreER allele for its potential impact on Tbr1 function and complementation to Tbr1 loss-of-function alleles. In mice with one copy of the Tbr1-2A-CreER allele, we identified reduction of TBR1 protein in early postnatal cortex along with thinning of the AC, suggesting hypersensitivity of this structure to TBR1 dosage. Comparing Tbr1-2A-CreER and Tbr1-null mice to Tbr1-null complementation crosses showed reductions of TBR1 dosage ranging from 20% to 100%. Using six combinatorial genotypes, we found that moderate to severe TBR1 reductions (≥44%) were associated with cortical layer 5 expansion, while only the complete absence of TBR1 was associated with reeler-like "inverted" cortical layering. In total, these results strongly support the conclusion that Tbr1-2A-CreER is a hypomorphic allele. We advise caution when interpreting experiments using this allele, considering the sensitivity of various corticogenic processes to TBR1 dosage and the association of heterozygous TBR1 mutations with complex neurodevelopmental disorders.
Autism research : official journal of the International Society for Autism Research, 2025 · doi:10.1002/aur.3271